|Year : 2019 | Volume
| Issue : 25 | Page : 16-23
Mangifera and Impatiens from Sumatra: Phylogenetic positions and their modes of action as anticancer agents
Agustina Dwi Retno Nurcahyanti
Department of Pharmacy, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
|Date of Web Publication||3-Apr-2019|
Dr. Agustina Dwi Retno Nurcahyanti
Department of Pharmacy, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jl. Pluit Raya No. 2, Penjaringan, Jakarta 14440
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Cancer has become a growing health threat due to the emergence of multidrug resistance and the increasing diversity of cancer cells. The continuous investigation into the development of anticancer agents and treatments is crucial because the current treatments can cause adverse side effects and are often ineffective. Anticancer derived medicinal plants are a potential source of treatment. However, the abundance of medicinal plant species can cause several problems, like the adulteration. The author aims to demonstrate DNA Barcoding technique as a tool to perform phylogenetic positions of Mangifera and Impatiens species grown in Sumatra. The phylogenetic positions of the plants are supported by the review on the active secondary metabolites from Mangifera and Impatiens. The current study is based on unpublished work on DNA Barcoding technique, an established modern technique to identify the phylogenetic position and also adulteration in medicinal plants. The review on the active secondary metabolites including the mechanism of action as anticancer is based on pertinent papers that were retrieved using relevant keywords in PubMed and Science Direct. Work using DNA Barcoding technique confirmed that Mangifera and Impatiens from Sumatra are closely related to Momordica foetida and Impatiens balsamina from other areas, indicating that they may share the same anticancer traits with those species. The mechanism of action of Mangifera and Impatiens includes inhibition of the cell cycle, cytotoxicity activity, apoptosis and leading to cell death, and anti-angiogenesis activity. Further research on both species is needed to identify their relevant chemical components to potentially develop anticancer drugs, either as a single compound or as a drug combination with minimal side effects and also to determine possible adverse reactions.
Keywords: Anticancer, Impatiens, Mangifera, phylogeny, Sumatra
|How to cite this article:|
Nurcahyanti AD. Mangifera and Impatiens from Sumatra: Phylogenetic positions and their modes of action as anticancer agents. Phcog Rev 2019;13:16-23
|How to cite this URL:|
Nurcahyanti AD. Mangifera and Impatiens from Sumatra: Phylogenetic positions and their modes of action as anticancer agents. Phcog Rev [serial online] 2019 [cited 2019 Jun 18];13:16-23. Available from: http://www.phcogrev.com/text.asp?2019/13/25/16/255391
| Introduction|| |
Cancer is one of the leading causes of morbidity and mortality worldwide. Data from the World Health Organization (WHO) suggested that there were approximately 14 million new cases in 2012 and that number is expected to increase by about 70% in the next 2 decades. Data in a global level suggested that nearly 1 in 6 deaths are due to cancer and about 70% of those cases are recorded from low- and middle-income countries. Besides behavioral and dietary risk, cancer can also occur due to infections, such as hepatitis and the human papillomavirus (HPV). About 25% of cancer cases in low- and middle-income countries are due to infections.
The common cause of mortality in cancer cases is late-stage presentation and inaccessible diagnosis and treatment. In 2015, only 35% of low-income countries reported having pathology services generally available in the public sector and to date, only 1 in 5 low- and middle-income countries have the necessary data to develop cancer policy. This needs to be improved since cancer is projected to be one of the major causes of death in this century. Globally, cancer treatment needs continuous development to keep up with this threat.
The current well-known anticancer drugs are becoming less effective due to drug resistance. Thus, new anticancer drugs, drug combinations, and chemotherapy strategies need to be developed. To achieve this, methodical and scientific research of synthetic, biological, and natural products is very important. The natural products are an abundant and well-known source for cancer treatment. There are at least 250,000 species of plants that contain thousands of chemical compounds possessing significant anticancer properties. Some of these compounds include vincristine, vinblastine, colchicine, ellipticine, lepachol, and flavopiridol, a semi-synthetic analog of the chromone alkaloid rohitukine from India and many more., Many naturally occurring molecules have shown promising anticancer activity, but a significant number of molecules have not yet been studied in detail.
The current article reviews the chemical structures and their mechanism of actions, along with describing the structure-function relationships of naturally derived anticancer agents at the molecular, cellular, and physiological levels of medicinal plants, the Mangifera species (Anacardiaceae) and Impatiens species (Balsaminaceae), which grow on Sumatra Island, Indonesia. To authenticate and identify both species, we performed DNA barcoding, which amplified the conserved region of the Internal Transcribed Spacer (ITS) and constructed the phylogenetic tree. This approach enables us to compare the genetic relationship of both species from Sumatra especially in Riau City with species grown in other countries.
Taxonomy, morphology, and phylogenetic position of Mangifera from Sumatra
Among the genus Mangifera, Mangifera indica is the most well-known species and one of the most important tropical plants in the world. M. indica has been known as several local names, such as Mabaz (Arab), Am/Um (Bengali), Mi wang (Chinese), Mango; Mangofrugt; Mangotrae (Danish), Manga; Mangga; Manja; Mangoestanboom (Dutch), Mango (English), Mango; Mangopuu (Finnish), Mangue; Manguier (French), Indischer Mangobaum; Mango (German), Magko; Mangko (Greek), Am; Ambi; Amia (Hindi), Anchaa; Mangoo; Mangou (Japanese), Amb (Persian), Aamra; Ambrah (Sanskrit), Amba (Sinhalese), Mangas; Mau; Mampalam (Tamil), and Mangga (Indonesia).
The taxonomical classification of Mangifera can be described as follow:
- Kingdom: Plantae
- Subkingdom: Tracheobionta
- Superdivision: Spermatophyta
- Division: Magnoliophyta
- Class: Magnoliopsida
- Subclass: Rosidae
- Order: Sapindales
- Family: Anacardiaceae
- Genus: Mangifera.
On the analysis of phylogenetic tree, [Figure 1] shows the amplification of ITS sequences of Mangifera species from Sumatra for DNA barcoding and thus shows the genetic relationship with other Mangifera species distributed outside Indonesia (our unpublished work). The phylogenetic analysis is based on a representative sampling of the genus Mangifera, which includes 10 GenBank accessions. Another Anarcadiaceae, Searsia pyroides serves as an outgroup for the phylogeny reconstruction. As shown in [Figure 1], the phylogeny reconstruction reveals three major clades, supported with high bootstrap P values. Mangifera from Sumatra locally called as Ambacang clusters together with Momordica foetida as a sister group with high bootstrap support [Figure 1]. This is the first report showing that Ambacang represents M. foetida and identical to M. foetida that grows in Japan (Accession Number AB071680.1).
|Figure 1: Molecular phylogenetic analysis of Mangifera from Sumatra, called Ambacang as compared to related Mangifera species generated from NJ analysis|
Click here to view
Fitmawati et al. (2016) also identified Mangifera species in Central Sumatra and suggested that evolution tree from ten Mangifera species formed two clades with bootstra P value 100%. Those clades are Clade I consists of M. quadrifida and Clade II includes Mangifera sp., M. torquenda, M. sumatrana, M. foetida, M. odorata, M. zeylanica, M. indica, M. laurina, and M. kemanga. In that study, Clade II developed into two subclade, namely subclade IIA consists of Mangifera sp., M. torquenda and M. sumatrana while subclade IIB consists of two groups were split M. foetida and M. odorata with M. zeylanica, M. indica, M. laurina and M. kemanga. Using Neighbor Joining (NJ) analysis, Mangifera species reconstructed three clades, which are Clade I includes M. quadrifida while Clade II includes monophyletic groups of Mangifera sp., M. torquenda and M. sumatrana, and Clade III includes M. foetida, M. odorata, M. zeylanica, M. indica, M. laurina and M. kemanga (Fitmawati et al., 2016). The main difference in the NJ tree compared with the parsimonious tree was the position of Clade II and Clade III. In parsimony analysis, both clades formed a larger monophyletic group indicating they share common ancestor whereas in NJ analysis both clades were separate and resulted multifurcating tree, as has been seen in the current study. Kim and Mabry suggested some transition leaf texture relatively toward coriaceous or chartaceous such as M. quadrifida and M. torquenda indicating biparental inherited from nuclear genome. Therefore, Mangifera species which has transition leaf texture is a natural hybrid from different parental such as M. odorata hybrid from M. foetida and M. indica. Leaf structures of Mangifera used in this study, M. foetida and M. indica can be seen in [Figure 2]. Based on the morphological leaf and the genomic result as seen in phylogenetic tree [Figure 1], Mangifera species used in this study is closely related to M. foetida and share genetic compartment of M. indica. Thus, it indicates Mangifera species naturally produce nature anticancer chemicals as contains in M. indica. This hypothesis needs further anticancer identification and chemical structure analysis of mangiferin, the main anticancer compound of M. indica.
|Figure 2: Mangifera used in current study gathered from Sumatra (above), Momordica foetida (below left), Mangifera indica (below right),|
Click here to view
Initial tree(s) for the heuristic search were obtained automatically by applying NJ, and BioNJ algorithms to a matrix of pairwise distances estimated using the (Maximum Likelihood) ML approach and then selecting the topology with superior log-likelihood value. The analysis involved 10 nucleotide sequences. Evolutionary analyses were conducted in MEGA 6.
Taxonomy, morphology, and phylogenetic position of Impatiens from Sumatra
Impatiens balsamina is one of the most important tropical plants in the world that belong to the genus of Impatiens. The common names of I. balsamina include Garden balsam, rose balsam, spotted snapweed, touch-me-not (English), Gul-mehndi (Hindi), Basava paadadagida (Canada), Tilo-onapu (Malay), Khujang lei (Manipuri), Chrido; Terada (Marathi), Tiuree (Nepal), Tairini (Sanskrit), Aivartenkittumpai; Aivartyenki (Tamil), Chilaka mukka puvvu; kaasithummi; Kasi tummi (Telugu), Gul-mehndi (Urdu), and Pacar air (Indonesia).
The taxonomical classification of I. balsamina can be described as follow:
- Kingdom: Plantae
- Division: Magnoliophyta
- Class: Magnoliopsida
- Order: Ericales
- Family: Balsaminaceae
- Genus: Impatiens
- Species: I. balsamina.
[Figure 3] shows the amplification of ITS sequences of Impatiens gathered from Sumatra for DNA barcoding and thus shows the genetic relationship with other Impatiens species distributed outside Indonesia (our unpublished work). The phylogenetic analysis is based on a representative sampling of the genus Impatiens, which includes 28 GenBank accessions. Another Balsaminaceae, Anagallis arvensis serves as an outgroup for the phylogeny reconstruction. As shown in [Figure 3], the phylogeny reconstruction reveals two major clades, supported with high bootstrap P values. Impatiens from Riau, Sumatra clusters together with I. balsamina from Thailand (KC 905466.1) as a sister group with high bootstrap support [Figure 3]. This is the first report showing that Impatiens from Riau [Figure 4], Sumatra genetically similar to several Impatiens species that grows in other countries [Figure 3].
|Figure 3: Molecular Phylogenetic analysis of Pacar Air as compared to related Impatiens species generated from NJ analysis|
Click here to view
Initial tree(s) for the heuristic search were obtained automatically by applying NJ and BioNJ algorithms to a matrix of pairwise distances estimated using the ML approach and then selecting the topology with superior log-likelihood value. The analysis involved 28 nucleotide sequences. Evolutionary analyses were conducted in MEGA 6.
Anticancer activity of Mangifera and Impatiens
Extended studies reported that M. indica possesses anticancer activity as well a few numbers of studies suggest I. balsamina also performed the activity. The prominent anticancer compound from the Mangifera species is mangiferin [Figure 5], and the prominent anticancer compound from the Impatiens species is balsaminone [Figure 6]. This review also describes other promising chemical compounds that might be beneficial to the development of new drug combinations, as well as chemical modifications for enhanced administration of anticancer drugs. The following paragraph describes the chemical structures of the anticancer compounds and their modes of action.
|Figure 5: Chemical structures of secondary metabolites from Mangifera species|
Click here to view
|Figure 6: Chemical structures of secondary metabolites from Impatiens balsamina|
Click here to view
Biological activity and the active compounds from genus Mangifera
Mango (M. indica L.), one of the most popular fruits in the tropics have been studied widely for their pharmacological activity. Most parts of the mango, such as the stem, bark, leaves, and pulp are known for various medical applications, including their antioxidant,, anti-inflammatory, and anticancer properties, as we will discuss further in the current review.
The anticancer activity of Mangifera is found not only in the leaves, flesh, and stem but also in the peel. Kim et al. suggested that the antioxidant and antiproliferative activities of mango peels might be due to the synergistic actions of its bioactive compounds. This phenomenon needs further investigation, especially because mango peel can be further processed and has shown potential as a functional food and a valuable food ingredient. Several studies have been performed to investigate the pharmacological potential of the Mangifera species both in vitro and in vivo.In vitro studies have described several mechanisms of action of the anticancer compounds found in Mangifera.
Mechanisms of action of Mangifera based on in vitro studies
Inhibition of the cell cycle
In past studies, researchers proved that the juice and fruit extract from M. indica L showed inhibition for the cell cycle in G (0)/G (1) phase in the in vitro model in BALB/3T3 cells and HL-60 cells. Several polyphenols compounds contained in M. indica have been studied and exhibited increasing mRNA expression of pro-apoptotic biomarkers and cell cycle arrest, which has been tested in several cancer cell line such as leukemia, lung, breast, prostate, and colon. The compound from Mangifera species that is responsible for the activity to arrest the cell cycle (delay the S phase, arrest G2/M phase) is called mangiferin. Some studies revealed that mangiferin induces G2/M phase arrest in HL-60 cell strains, and increases CDC2, Cyclin B1, Cyclin A, Wee1, CDC25C, and Chk1 mRNA expression level of HL-60 cells. The G2/M phase arrest activity by mangiferin indicates that it possesses anti-leukemia properties., Abu Bakar et al. proved that a crude extract of M. panjang is capable of inducing G2-M arrest, resulting in substantial sub-G1 apoptosis arrest and apoptosis.
Several compounds contained in M. indica L, such as butylated hydroxytoluene, 4,6-di (1,1-dimethylethyl)-2-methyl, fumaric acid, butylated hydroxytoluene, 4,6-di (1,1-dimethylethyl)-2-methyl, fumaric acid, 2-decyl undecyl ester, isoheptadecanol (1-Hexadecanol, 2-methyl), Apigenin 7-glucoside, cis-5 Dodecenoic acid, and (3-cyanopropyl) dimethylsilyl ester showed cytotoxicity to breast cancer cell lines with IC50 values of 30 and 15 μg/mL. Cycloartane-type triterpenes, mangiferolate, mangiferolate B, and isoambolic acid from M. indica L inhibit the growth of human pancreatic cancer cell lines, such as the PANC-1 line.
Apoptosis and leading to cell death
Mangiferin from the pulp, peel, seed, bark, and the leaf of the Mangifera species shows decreasing expression of PARP, caspase 9, 7, and 3, leading to apoptosis. The loss of mitochondrial membrane potential is also an indicator of the death of cells., Mangiferin also shows an activity to downregulate bcr/abl expression, leading to an apoptosis induction. Mangiferin also induced apoptosis in K562 cell lines through reduced bcr/abl fusion protein P210, B-Cell Lymphoma-2 (Bcl-2) and surviving mRNA gene expression, and increased bax gene expression. Pan et al. suggests that there is downregulation of Bcl-2 expression, while those of Bax were up-regulated. Padma et al. (2015) discovered that mangiferin was found to induce apoptosis by increasing caspase-3 activity and DNA fragmentation. Mangiferin also mediated down-regulation of nuclear factor-kappaB (NF-κB) and showed potential for chemotherapeutic agent-mediated cell death especially because it does not change the expression of other survival signal-regulated kinase ½, protein kinase B, and p38 mitogen-activated protein. The mechanism of mangiferin in inducing cell death is also by increasing the release of lactate dehydrogenase leakage and nitric oxide. This has been observed in embryonic rhabdomyosarcoma and in the most prevalent types of cancer among children. Mangiferin also caused cell shrinkage and nuclear condensation, along with the occurrence of a late event of apoptosis. The crude extract from M. panjang has the capability of inducing apoptosis dependent on the caspase-2 and-3 in MCF-7 cells, and on caspase-2,-3 and-9 in MDA-MB-231 cells. Kim et al. (2012) observed that mangiferin inhibits cell proliferation. The mechanism of effect is possibly related to inducing apoptosis and the expression of the Fas protein.
Mangiferin is capable of modulating several key inflammatory pathways that induce carcinogenesis by decreasing several responsible genes and pathways such as NF-κB, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκB-α), Janus Kinase 1/2 (JAK-1/2), Signal transducer and activator of transcription 3 (STAT3), AKT, Mitogen-Activated Protein Kinase, and IκB kinase (IκK). NF-κB down-regulation is essential for regulating the expression of cyclooxygenase-2, intercellular Adhesion Molecule-1 (ICAM-1), Bcl-2, interleukin-6 (IL-6), IL-8, C-X-C Chemokine Receptor type-4 (CXCR4), X-linked Inhibitor of Apoptosis Protein, and Vascular Endothelial Growth Factor (VEGF), which is involved in inflammation, metastasis, cell survival, and angiogenesis.,, Mangiferin acts as a down-regulator of NF-κB, resulting in the reduction of the genes listed above, and increased apoptosis. Mangiferin was also observed to downregulate IL-6 and IL-8 inflammatory cytokines production when stimulated by tumor necrosis factor (TNF), thus resulting in reducing the inflammatory response.
Mangiferin also reduces the expression of VEGF, TNF-α, and fibroblast growth factor. The progression of cancer cells to tumor formation requires the ability to produce a blood supply containing nutrients and oxygen. This is known as tumor angiogenesis. It has been widely known that the VEGF-A protein stimulates angiogenesis. García-Rivera et al. demonstrated an inhibitory effect of mangiferin extract on TNF-induced transcription of VEGF-A in MDA-MB231 cells. This finding needs further long-term investigation and evidence from in vivo/ex vivo studies.
Mangiferin (C-glucosylated xanthone) from the pulp, peel, seed, bark, and leaf possess the antioxidant property to decrease oxygen free radicals, thereby reducing the DNA damage. Moreover, the antioxidant activity of the Mangiferin species is enhanced by the presence of its polyphenols compounds.
In addition to mangiferin, other polyphenols found in Mangifera that have potential antioxidant activity include mangiferin gallate, isomangiferin, isomangiferin gallate, quercetin 3-O-gallactoside, quercetin 3-O-glucoside, quercetin 3-O-xyloside, quercetin 3-O-arabinopyranoside, quercetin 3-O-arabinufuranoside, quercetin 3-O-rhamnoside, kaempferol 3-O-glucoside, rhamnetin 3-O-galactoside/glucoside, and quercetin.
During mango fruit development, phenol concentration has been found to be higher in the peel than in the flesh at all stages. In general, ripe peels contain higher total polyphenols than raw peels. Berardini et al. found that, while mangiferin contents slightly decreased at elevated temperatures, the contents of the other xanthone derivatives significantly increased.
Berardini et al. established the antioxidative activity of mango peel extract and suggested that the antioxidative capacity of the extract was higher than that of standard mangiferin and quercetin 3-O-glucoside. The result indicates that the antioxidative capacity of the peel extract works synergistically with the other compounds.
The most prominent compounds that displayed antioxidant activity are mangiferin, methyl gallate, gallic acid (pro-oxidant), penta-O-galloyl-glucoside, ascorbic acid (pro-oxidant), and Trolox. Penta-O-galloyl-glucoside and mangiferin, when tested individually, were potent inhibitors of xanthine oxidase, while gallic acid and ascorbic acid displayed pro-oxidant activity. Penta-O-galloyl-glucoside is the major compound detected in the peels and kernels of the mango by products, with higher concentrations found in the kernels when compared to the peels. In the bark and young leaves, the predominant compound detected was mangiferin an important molecule with potential pharmacologic activities.,
Drug combination of mangiferin with other chemotherapeutic drugs
Combinations of mangiferin with other chemotherapeutic drugs resulted in superior effects. Mangiferin combined with oxaliplatin shows promising activity by reducing oxaliplatin IC50 in HT29 (3.4-fold) and HeLa (1.7-fold) in vitro. This activity is also aided by increasing the activity of caspase-3 and DNA fragmentation delay in the S-phase of the cell cycle. Mangiferin can also be combined with oxaliplatin. This study indicates these combinations favor apoptotic cell death. Combinations of mangiferin with other natural products, such as gallic acid, can inhibit NF-κB activation by IκK-γ®, resulting impaired IκB degradation, NF-κB translocation, and NF-κB/DNA binding. Combinations of mangiferin with other chemotherapeutic drugs with various targets and modes of action reduces side effects while improving nutrition levels.
Mechanisms of action of Mangifera based on in vivo studies
Several in vivo studies of mangiferin have been conducted. Li et al. (2013) observed decreased tumor volume, weight, and proliferation, and increased apoptosis in mangiferin-treated MDA-MB-231 xenograft mice. It decreased the expression of MMP-7 and-9, vimentin, activated®-catenin, and increased the expression of E-cadherin. More recent publications have shown that in A549 xenograft mice in vivo, mangiferin exhibited anti-tumor properties and markedly decreased the volume and weight of subcutaneous tumor mass, which lengthened lifespan. Moreover, in combination with cisplatin, mangiferin enhanced its antiproliferative effects, thus indicating the potential for a combined therapy. In vivo tests have also been conducted in various animal models of cancer. In one such test, mangiferin exhibited chemopreventive effects in Swiss Albino mice treated with the compound (50 mg/kg body weight) for 6 weeks., Rajendran et al. also reported that cancer-bearing animals pretreated with mangiferin exhibited reduced alveolar damage with a nearly normal architecture. Animals posttreated with mangiferin showed slightly reduced alveolar damage. Mice treated with mangiferin alone showed no significant change in lung histology from that of the control animals.
Leiro et al. studied the immunomodulatory activity of mangiferin on the expression of several genes related to the NF-κB signaling pathway using activated mouse macrophages. The inhibition of gene expression by mangiferin at a concentration 10 μM includes (1) the genes Rel/NF-κB/IκB family, RelA and RelB (=I-rel) indicates an inhibitory effect on NF-κB-mediated signal transduction, (2) TNF receptor (TNF-R)-associated factor 6 (Traf6), resulting in probable blockage of the activation of the NF-κB pathway by lipopolysaccharide, TNF, or IL-1, (3) proteins involved in responses to TNF and apoptotic pathways triggered by DNA damage includes TNF-R, the TNF-receptor-associated death domain, and the receptor-interacting protein, (4) extracellular ligand IL-1a, indicating likely interference with responses to IL-1, (5) the pro-inflammatory cytokines IL-1, IL-6, IL-12, TNF-α, regulated on activation, normal T-cell expressed and secreted known as chemokine (C-C motif) ligand 5 (CCL5), and cytokines produced by monocytes and macrophages including granulocyte colony-stimulating factor (CSF), granulocyte-macrophage CSF, macrophage CSF, (6) other toll-like receptor proteins including c-Jun N-terminal kinases (JNK1, JNK2) and Tab1 gene, (7) Scya2 (small inducible cytokine A2); and (8) various ICAMs, as well as the Vascular Cell-Adhesion Molecule in high concentrations in atheromas. The inhibition of JNK1, together with stimulation of c-JUN like the Jun oncogene suggests that mangiferin may protect cells form oxidative damage and mutagenesis and it has been also previously proved in term of the antioxidant activity.
The administration of mangiferin to rats with D-galactosamine-induced hepatoxicity alters all adverse effects. This indicates that mangiferin has a hepatoprotective role due to the induction of antioxidant defense via the NRF2 pathway and the reduction of inflammation pathways via the inhibition of NF-κB activity. Guha et al. (1996) also showed mangiferin to have in vivo growth inhibitory activity against ascetic fibrosarcoma in Swiss mice. In murine splenocytes and thymocytes, mangiferin activated the splenocytes of tumor hosts at early and late stages of tumor growth. The phytohemagglutinin and Con A unresponsive splenocytes of advanced tumor bearers proliferated extensively in response to mangiferin. Mangiferin, when used with Con A, produced additive stimulatory effect and induced heightened DNA synthesis of normal and advanced tumor bearers' splenocytes.
Biological activity and the active compounds from genus Impatiens
I. balsamina L. is one of the medicinal plants widely distributed and used as an indigenous medication in Asia for the treatment of rheumatism, fractures and fingernail inflammation. Lobstein et al. isolated anti-Helicobacter pylori compounds from the pods, roots, stems and leaves of I. balsamina L, called 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3 β-ol (spinasterol). The activity of 2-methoxy-1,4-naphthoquinone was equivalent to that of amoxicillin. The compound exhibits great potential to be developed as an agent for the eradication of H. pylori infection and exhibits thermal and pH stability., Compounds of 2-methoxy-1,4-naphthoquinone have also shown antifungal and antibacterial activities.,
Several quinone compounds were observed, such as natural bisnaphthoquinone, methylene-3,3'-bilawsone, which was isolated from root cultures of I. balsamina, along with two naphthoquinones (lawsone and 2-methoxy-l, 4-naphthoquinone), two coumarin derivatives (scopoletin and isofraxidin), and a sterol (spinasterol).,
Ethanol extracts of I. balsamina were also investigated for anticancer and in vitro cytotoxic activities against transplantable tumors and human cell lines. The extract was examined using two methods, in vitro cytotoxicity using Hela and NH3T3, and in vivo using Dalton's Ascites Lymphoma (DLA) tumor-bearing mice. The extract showed less toxicity against normal cells. The results indicated significant antitumor and cytotoxic effects against DLA and human cancer cell lines.
Ding et al. (2008) showed that extracts of ethanol or chloroform from I. balsamina exhibit anti-tumor activity against the human hepatocellular carcinoma cell line HepG2. From those extracts, 2-methoxy-1,4-naphthoquinone was discovered to be an active anticancer compound., Shin et al. investigated the efficacy of a methanol extract from I. balsamina L. against HSC-2 human oral cancer cells. The results also suggest that I. balsamina extract is promising as an oral cancer treatment through the mechanism of action of adenosine monophosphate-activated protein kinase and t-Bid. Several compounds contained in I. balsamina possess anticancer activities, and that have been summarized in [Table 1]. Other potential chemical compounds are described in [Figure 6].
|Table 1: Several compounds contained in Impasiens balsamina possess anticancer activities|
Click here to view
| Conclusion|| |
Taken together, phylogenetic analysis showed that the Mangifera and Impatiens species from Sumatra share a close relationship with M. foetida and M. indica and I. balsamina from other countries. The results indicate a modulation of the expression of genes that are critical for the regulation of apoptosis, anti-tumorigenesis, and anti-inflammation. This raises the possibility that they may be of value for the treatment of inflammatory diseases and/or cancer as a single active compound, as an active fraction, or in combination with chemotherapeutic drugs. Further investigation is urgently needed, one of them to identify the abundance of mangiferin and other anti-cancer compounds contained in Mangifera from Sumatra and anticancer compounds of Impatiens.
The author is grateful to School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia for the financial funding.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al.
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
Kumara PM, Soujanya KN, Ravikanth G, Vasudeva R, Ganeshaiah KN, Shaanker RU, et al.
Rohitukine, a chromone alkaloid and a precursor of flavopiridol, is produced by endophytic fungi isolated from Dysoxylum binectariferum
and Amoora rohituka
(Roxb).wight & arn. Phytomedicine 2014;21:541-6.
Safia, Kamil M, Jadiya P, Sheikh S, Haque E, Nazir A, et al.
The chromone alkaloid, rohitukine, affords anti-cancer activity via modulating apoptosis pathways in A549 cell line and yeast mitogen activated protein kinase (MAPK) pathway. PLoS One 2015;10:e0137991.
Fitmawati, Ibna H, Sofiyanti N. Short communication: Using ITS as a molecular marker for Mangifera
species identification in Central Sumatra. Biodiversitas 2016;17:653-6.
Kim KJ, Mabry TJ. Phylogenetic and evolutionary implications of nuclear ribosomal DNA variation in dwarf dandelions (Krigia
, Lactuceae, Asteraceae
). Plant Syst Evol 1991;177:53-69.
Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016;33:1870-4.
Ajila CM, Bhat SG, Prasada RU. Valuable components of raw and ripe peels from two Indian mango varieties. Food Chem 2007;102:1006-11.
Rocha Ribeiro SM, Queiroz JH, Lopes Ribeiro de Queiroz ME, Campos FM, Pinheiro Sant'ana HM. Antioxidant in mango (Mangifera indica
L.) pulp. Plant Foods Hum Nutr 2007;62:13-7.
Hernandez P, Rodriguez PC, Delgado R, Walczak H. Protective effect of Mangifera indica
L. Polyphenols on human T lymphocytes against activation-induced cell death. Pharmacol Res 2007;55:167-73.
Percival SS, Talcott ST, Chin ST, Mallak AC, Lounds-Singleton A, Pettit-Moore J, et al.
Neoplastic transformation of BALB/3T3 cells and cell cycle of HL-60 cells are inhibited by mango (Mangifera indica
L.) juice and mango juice extracts. J Nutr 2006;136:1300-4.
Kim H, Moon JY, Kim H, Lee DS, Cho M, Choi HK, et al
. Antioxidant and antiproliferative activities of mango (Mangifera indica
L.) flesh and peel. Food Chem 2010;121:429-36.
Noratto GD, Bertoldi MC, Krenek K, Talcott ST, Stringheta PC, Mertens-Talcott SU, et al.
Anticarcinogenic effects of polyphenolics from mango (Mangifera indica
) varieties. J Agric Food Chem 2010;58:4104-12.
Khurana RK, Kaur R, Lohan S, Singh KK, Singh B. Mangiferin: A promising anticancer bioactive. Pharm Pat Anal 2016;5:169-81.
Peng ZG, Yao YB, Yang J, Tang YL, Huang X. Mangiferin induces cell cycle arrest at G2/M phase through ATR-chk1 pathway in HL-60 leukemia cells. Genet Mol Res 2015;14:4989-5002.
Yao YB, Peng ZG, Liu ZF, Yang J, Luo J. Effects of mangiferin on cell cycle status and CDC2/Cyclin B1 expression of HL-60 cells. Zhong Yao Cai 2010;33:81-5.
Abu Bakar MF, Mohamad M, Rahmat A, Burr SA, Fry JR. Cytotoxicity, cell cycle arrest, and apoptosis in breast cancer cell lines exposed to an extract of the seed kernel of Mangifera pajang
(bambangan). Food Chem Toxicol 2010;48:1688-97.
Abdullah AS, Mohammed AS, Abdullah R, Mirghani ME, Al-Qubaisi M. Cytotoxic effects of Mangifera indica
L. Kernel extract on human breast cancer (MCF-7 and MDA-MB-231 cell lines) and bioactive constituents in the crude extract. BMC Complement Altern Med 2014;14:199.
Nguyen HX, Do TN, Le TH, Nguyen MT, Nguyen NT, Esumi H, et al.
Chemical constituents of Mangifera indica
and their antiausterity activity against the PANC-1 human pancreatic cancer cell line. J Nat Prod 2016;79:2053-9.
Li M, Ma H, Yang L, Li P. Mangiferin inhibition of proliferation and induction of apoptosis in human prostate cancer cells is correlated with downregulation of B-cell lymphoma-2 and upregulation of microRNA-182. Oncol Lett 2016;11:817-22.
Peng ZG, Luo J, Xia LH, Chen Y, Song SJ. CML cell line K562 cell apoptosis induced by mangiferin. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004;12:590-4.
Pan LL, Wang AY, Huang YQ, Luo Y, Ling M. Mangiferin induces apoptosis by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal carcinoma cell line. Asian Pac J Cancer Prev 2014;15:7065-8.
Padma VV, Kalaiselvi P, Yuvaraj R, Rabeeth M. Mangiferin induces cell death against rhabdomyosarcoma through sustained oxidative stress. Integr Med Res 2015;4:66-75.
Shoji K, Tsubaki M, Yamazoe Y, Satou T, Itoh T, Kidera Y, et al.
Mangiferin induces apoptosis by suppressing Bcl-xL and XIAP expressions and nuclear entry of NF-κB in HL-60 cells. Arch Pharm Res 2011;34:469-75.
Kim H, Kim H, Mosaddik A, Gyawali R, Ahn KS, Cho SK, et al.
Induction of apoptosis by ethanolic extract of mango peel and comparative analysis of the chemical constitutes of mango peel and flesh. Food Chem 2012;133:416-22.
du Plessis-Stoman D, du Preez J, van de Venter M. Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFκB in cancer cell lines. Afr J Tradit Complement Altern Med 2011;8:177-84.
Duang XY, Wang Q, Zhou XD, Huang DM. Mangiferin: A possible strategy for periodontal disease to therapy. Med Hypotheses 2011;76:486-8.
Zhang B, Fang J, Chen Y. Antioxidant effect of mangiferin and its potential to be a cancer chemoprevention agent. Lett Drug Des Discov 2013;10:239-44.
García-Rivera D, Delgado R, Bougarne N, Haegeman G, Berghe WV. Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica
L. bark in MDA-MB231 breast cancer cells. Cancer Lett 2011;305:21-31.
Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-74.
Lakshminarayana S, Subhadra NV, Subramanyam H. Some aspects of developmental physiology of mango fruit. J Hortic Sci 1970;45:133-42.
Berardini N, Schieber A, Klaiber I, Beifuss U, Carle R, Conrad J. 7-O-methylcyanidin 3-O-ß-D-galactopyranoside, a novel anthocyanin from mango (Mangifera indica
L.) cv. 'Tommy Atkins' peels. Chem Sci 2005;60:801-4.
Barreto JC, Trevisan MT, Hull WE, Erben G, de Brito ES, Pfundstein B, et al.
Characterization and quantitation of polyphenolic compounds in bark, kernel, leaves, and peel of mango (Mangifera indica
L.). J Agric Food Chem 2008;56:5599-610.
Li H, Huang J, Yang B, Xiang T, Yin X, Peng W, et al.
Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. Toxicol Appl Pharmacol 2013;272:180-90.
Shi W, Deng J, Tong R, Yang Y, He X, Lv J, et al.
Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells. Mol Med Rep 2016;13:3423-32.
Rajendran P, Ekambaram G, Sakthisekaran D. Protective role of mangiferin against benzo(a) pyrene induced lung carcinogenesis in experimental animals. Biol Pharm Bull 2008;31:1053-8.
Rajendran P, Ekambaram G, Sakthisekaran D. Effect of mangiferin on benzo(a) pyrene induced lung carcinogenesis in experimental Swiss albino mice. Nat Prod Res 2008;22:672-80.
Leiro J, Arranz JA, Yáñez M, Ubeira FM, Sanmartín ML, Orallo F. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int Immunopharmacol 2004;4:763-78.
Guha S, Ghosal S, Chattopadhyay U. Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy 1996;42:443-51.
Chattopadhyay U, Das S, Guha S, Ghosal S. Activation of lymphocytes of normal and tumor bearing mice by mangiferin, a naturally occurring glucosylxanthone. Cancer Lett 1987;37:293-9.
Lobstein A, Brenne X, Feist E, Metz N, Weniger B, Anton R. Quantitative determination of naphthoquinones of Impatiens
species. Phytochem Anal 2001;12:202-5.
Wang YC, Li WY, Wu DC, Wang JJ, Wu CH, Liao JJ, et al. In vitro
activity of 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3β-ol from Impatiens balsamina
L. against multiple antibiotic-resistant Helicobacter pylori
. Evid Based Complement Alternat Med 2011;2011:704721.
Little JE, Sproston TJ, Foote MW. Isolation and antifungal action of naturally occurring 2-methoxy-1,4-naphthoquinone. J Biol Chem 1948;174:335-42.
Yang X, Summerhurst DK, Koval SF, Ficker C, Smith ML, Bernards MA. Isolation of an antimicrobial compound from Impatiens balsamina
L. using bioassay-guided fractionation. Phytother Res 2001;15:676-80.
Panjchayupakaranant P, Noguchi H, De-Eknamkul W, Sankawa U. Naphthoquinones and coumarins from Impatiens balsamina
root cultures. Phytochemistry 1995;40:1141-3.
Baskar N, Devi BP, Jayakar B. Anticancer studies on ethanol extract of Impatiens balsamina
. Int J Res Ayurveda Pharm 2012;3:631-3.
Ding ZS, Jiang FS, Chen NP, Lv GY, Zhu CG. Isolation and identification of an anti-tumor component from leaves of Impatiens balsamina
. Molecules 2008;13:220-9.
Shin JA, Kwon KH, Cho SD. AMPK-activated protein kinase activation by Impatiens balsamina
L. is related to apoptosis in HSC-2 human oral cancer cells. Pharmacogn Mag 2015;11:136-42.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]